> But the first clinical trial to test that theory has found that a common antiviral for herpes simplex infections, valacyclovir, does not change the course of the disease for patients in the early stages of Alzheimer's.
https://www.cuimc.columbia.edu/news/antiviral-treatment-fail...
Yeah they looked at 120 people age 71 and above for that study. By that point its a little late.